BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27472704)

  • 1. Association of β-blocker therapy with long-term clinical outcomes in patients with coronary chronic total occlusion.
    Hwang JK; Yang JH; Hwang JW; Jang WJ; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC; Choi SH
    Medicine (Baltimore); 2016 Jul; 95(30):e4300. PubMed ID: 27472704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Survival Benefit of Statin in Patients with Coronary Chronic Total Occlusion without Revascularization.
    Kim BS; Yang JH; Jang WJ; Song YB; Hahn JY; Choi JH; Choi KH; Kim SH; Chun WJ; Gwon HC; Choi SH
    J Korean Med Sci; 2018 Apr; 33(18):e134. PubMed ID: 29713254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal medical therapy may be a better initial strategy in patients with chronic total occlusion of a single coronary artery.
    Hwang JW; Yang JH; Choi SH; Hwang JK; Jang WJ; Hahn JY; Song YB; Choi JH; Lee SH; Gwon HC
    Int J Cardiol; 2016 May; 210():56-62. PubMed ID: 26930638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Chronic Total Coronary Occlusion Location on Long-term Survival After Percutaneous Coronary Intervention.
    Ahn JH; Yang JH; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC; Choi SH
    Rev Esp Cardiol (Engl Ed); 2019 Sep; 72(9):717-723. PubMed ID: 30301617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program.
    Xie JX; Gunzburger EC; Kaun L; Plomondon ME; Barón AE; Waldo SW; Virani SS; Maddox TM; Mavromatis K
    Circ Cardiovasc Qual Outcomes; 2019 Nov; 12(11):e005455. PubMed ID: 31665896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison Between Beta-Blockers with Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers with Angiotensin II Type I Receptor Blockers in ST-Segment Elevation Myocardial Infarction After Successful Percutaneous Coronary Intervention with Drug-Eluting Stents.
    Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Cardiovasc Drugs Ther; 2019 Feb; 33(1):55-67. PubMed ID: 30632033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful revascularization versus medical therapy in diabetic patients with stable right coronary artery chronic total occlusion: a retrospective cohort study.
    Yan Y; Zhang M; Yuan F; Liu H; Wu D; Fan Y; Guo X; Xu F; Zhang M; Zhao Q; Lyu S
    Cardiovasc Diabetol; 2019 Aug; 18(1):108. PubMed ID: 31434572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of beta-blocker therapy at discharge with clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Yang JH; Hahn JY; Song YB; Choi SH; Choi JH; Lee SH; Kim JH; Ahn YK; Jeong MH; Choi DJ; Park JS; Kim YJ; Park HS; Han KR; Rha SW; Gwon HC
    JACC Cardiovasc Interv; 2014 Jun; 7(6):592-601. PubMed ID: 24947717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison between statin with ACE inhibitor or ARB therapy in STEMI patients who underwent successful PCI with drug-eluting stents.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Atherosclerosis; 2019 Oct; 289():109-117. PubMed ID: 31491742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Outcomes at 2 Years Between Beta-Blockade with ACE Inhibitors or ARBs in Patients with AMI Who Underwent Successful PCI with DES: A Retrospective Analysis of 23,978 Patients in the Korea AMI Registry.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Am J Cardiovasc Drugs; 2019 Aug; 19(4):403-414. PubMed ID: 30788675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of multiple chronic total occlusions in coronary arteries according to three therapeutic strategies: Bypass surgery, percutaneous intervention and medication.
    Kim BS; Yang JH; Jang WJ; Song YB; Hahn JY; Choi JH; Kim WS; Lee YT; Gwon HC; Lee SH; Choi SH
    Int J Cardiol; 2015 Oct; 197():2-7. PubMed ID: 26113468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
    Werner GS; Martin-Yuste V; Hildick-Smith D; Boudou N; Sianos G; Gelev V; Rumoroso JR; Erglis A; Christiansen EH; Escaned J; di Mario C; Hovasse T; Teruel L; Bufe A; Lauer B; Bogaerts K; Goicolea J; Spratt JC; Gershlick AH; Galassi AR; Louvard Y;
    Eur Heart J; 2018 Jul; 39(26):2484-2493. PubMed ID: 29722796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of angiotensin-converting enzyme inhibitors and beta blockers on clinical outcomes in patients with and without coronary artery obstructions at angiography (from a Register-Based Cohort Study on Acute Coronary Syndromes).
    Manfrini O; Morrell C; Das R; Barth JH; Hall AS; Gale CP; Cenko E; Bugiardini R;
    Am J Cardiol; 2014 May; 113(10):1628-33. PubMed ID: 24698468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blockers and cardiovascular outcomes in dialysis patients: a cohort study in Ontario, Canada.
    Kitchlu A; Clemens K; Gomes T; Hackam DG; Juurlink DN; Mamdani M; Manno M; Oliver MJ; Quinn RR; Suri RS; Wald R; Yan AT; Garg AX
    Nephrol Dial Transplant; 2012 Apr; 27(4):1591-8. PubMed ID: 21873621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin system blockade reduces cardiovascular events in nonheart failure, stable patients with prior coronary intervention.
    Choi Y; Lim S; Lee KY; Park HW; Byeon J; Hwang BH; Kim JJ; Oh YS; Youn HJ; Jung WS; Seung KB; Chang K
    Coron Artery Dis; 2018 Sep; 29(6):451-458. PubMed ID: 29489465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal Medical Therapy vs. Percutaneous Coronary Intervention for Patients With Coronary Chronic Total Occlusion - A Propensity-Matched Analysis.
    Yang JH; Kim BS; Jang WJ; Ahn J; Park TK; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC; Choi SH
    Circ J; 2016; 80(1):211-7. PubMed ID: 26581754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study.
    Sorbets E; Steg PG; Young R; Danchin N; Greenlaw N; Ford I; Tendera M; Ferrari R; Merkely B; Parkhomenko A; Reid C; Tardif JC; Fox KM;
    Eur Heart J; 2019 May; 40(18):1399-1407. PubMed ID: 30590529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion.
    Lee SW; Lee PH; Ahn JM; Park DW; Yun SC; Han S; Kang H; Kang SJ; Kim YH; Lee CW; Park SW; Hur SH; Rha SW; Her SH; Choi SW; Lee BK; Lee NH; Lee JY; Cheong SS; Kim MH; Ahn YK; Lim SW; Lee SG; Hiremath S; Santoso T; Udayachalerm W; Cheng JJ; Cohen DJ; Muramatsu T; Tsuchikane E; Asakura Y; Park SJ
    Circulation; 2019 Apr; 139(14):1674-1683. PubMed ID: 30813758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
    Høgh AL
    Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.